Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent

K-Number: K172289 · 2017-10-04

ApplicantQ Urological Corporation
Decision Date2017-10-04
Product CodeFAD
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent is a medical device manufactured by Q Urological Corporation. It received FDA 510(k) clearance on 2017-10-04 under approval number K172289. The device is classified under product code FAD. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent?

pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent is a medical device that received FDA 510(k) clearance on 2017-10-04. It is manufactured by Q Urological Corporation. The 510(k) number is K172289.

When was pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent approved by the FDA?

pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent received FDA 510(k) clearance on 2017-10-04, under approval number K172289.

What company makes pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent?

pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent is manufactured by Q Urological Corporation.

What is the FDA product code for pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent?

The FDA product code for pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent is FAD.

Related Clinical Trials

NCT07545512 ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY NOT_YET_RECRUITING NCT07592611 Deep Brain Stimulation for Treatment-Resistant Schizophrenia NOT_YET_RECRUITING NCT02361554 Deep Brain Stimulation in Treatment Resistant Schizophrenia TERMINATED NCT07580963 Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths NOT_YET_RECRUITING NCT06034847 Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy WITHDRAWN NCT06719089 Evaluation of the Safety and Performance of the Hydrustent® Biodegradable Hydrogel Ureteral Stent RECRUITING

Other Devices by Q Urological Corporation

K163068pAguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent

Related Devices (Code: FAD)

K163068pAguaMedicina PERSISTENT Structural Hydrogel Ureteral StentQ Urological Corporation K161277ConvertX Nephroureteral Stent SystemBrightwater Medical K160891Ultrathane Endoureterotomy Stent SetCook Incorporated K151051Universa Soft Ureteral Stents and Stent SetsCook Incorporated K170362VORTEK HYDRO-COATED DOUBLE LOOP URETERAL STENTSColoplast Corp. K170422BIOSOFT DUO DOUBLE LOOP URETERAL STENTSColoplast Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑